Deferred Tax Assets, Valuation Allowance of NextCure, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
NextCure, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • NextCure, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $131,903,000, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

NextCure, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $131,903,000 +$16,594,000 +14% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q4 2024 $115,309,000 +$16,349,000 +17% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q4 2023 $98,960,000 +$19,236,000 +24% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q4 2022 $79,724,000 +$22,019,000 +38% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q4 2021 $57,705,000 +$20,153,000 +54% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q4 2020 $37,552,000 +$11,919,000 +46% 31 Dec 2020 10-K 03 Mar 2022 2021 FY
Q4 2019 $25,633,000 +$10,108,000 +65% 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q4 2018 $15,525,000 31 Dec 2018 10-K 12 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.